Repaglinide stimulates insulin secretion through a different mechanism of action
Tuesday, June 26, 2001 08:00 IST A Correspondent, Philadelphia, PA
A new study suggests the oral antidiabetic drug (OAD) repaglinide stimulates insulin secretion by the pancreas through a different mechanism than nateglinide and tolbutamide, OADs prescribed to treat Type 2 diabetes.
